Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-06

FDA Approved: CLOBAZAM — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for CLOBAZAM (clobazam) submitted by Micro Labs Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)